Thalassemia (patient information)

Jump to: navigation, search

For the WikiDoc page for this topic, here

MedlinePlus 000587

WikiDoc Resources for Thalassemia (patient information)


Most recent articles on Thalassemia (patient information)

Most cited articles on Thalassemia (patient information)

Review articles on Thalassemia (patient information)

Articles on Thalassemia (patient information) in N Eng J Med, Lancet, BMJ


Powerpoint slides on Thalassemia (patient information)

Images of Thalassemia (patient information)

Photos of Thalassemia (patient information)

Podcasts & MP3s on Thalassemia (patient information)

Videos on Thalassemia (patient information)

Evidence Based Medicine

Cochrane Collaboration on Thalassemia (patient information)

Bandolier on Thalassemia (patient information)

TRIP on Thalassemia (patient information)

Clinical Trials

Ongoing Trials on Thalassemia (patient information) at Clinical

Trial results on Thalassemia (patient information)

Clinical Trials on Thalassemia (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Thalassemia (patient information)

NICE Guidance on Thalassemia (patient information)


FDA on Thalassemia (patient information)

CDC on Thalassemia (patient information)


Books on Thalassemia (patient information)


Thalassemia (patient information) in the news

Be alerted to news on Thalassemia (patient information)

News trends on Thalassemia (patient information)


Blogs on Thalassemia (patient information)


Definitions of Thalassemia (patient information)

Patient Resources / Community

Patient resources on Thalassemia (patient information)

Discussion groups on Thalassemia (patient information)

Patient Handouts on Thalassemia (patient information)

Directions to Hospitals Treating Thalassemia (patient information)

Risk calculators and risk factors for Thalassemia (patient information)

Healthcare Provider Resources

Symptoms of Thalassemia (patient information)

Causes & Risk Factors for Thalassemia (patient information)

Diagnostic studies for Thalassemia (patient information)

Treatment of Thalassemia (patient information)

Continuing Medical Education (CME)

CME Programs on Thalassemia (patient information)


Thalassemia (patient information) en Espanol

Thalassemia (patient information) en Francais


Thalassemia (patient information) in the Marketplace

Patents on Thalassemia (patient information)

Experimental / Informatics

List of terms related to Thalassemia (patient information)

Editor-in-Chief: C. Michael Gibson, M.S.,M.D. [1]; Associate Editor-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S.


Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form of hemoglobin, the protein in red blood cells that carries oxygen. The disorder results in excessive destruction of red blood cells, which leads to anemia.

What are the symptoms of Thalassemia?

  • The most severe form of alpha thalassemia major causes stillbirth (death of the unborn baby during birth or the late stages of pregnancy).
  • Children born with thalessemia major (Cooley's anemia) are normal at birth, but develop severe anemia during the first year of life.
  • Other symptoms can include:
  • Persons with the minor form of alpha and beta thalassemia have small red blood cells (which are identified by looking at their red blood cells under a microscope), but no symptoms.

What causes Thalassemia?

  • Hemoglobin is made of two proteins: Alpha globin and beta globin. Thalassemia occurs when there is a defect in a gene that helps control production of one of these proteins.
  • There are two main types of thalassemia:
  • Alpha thalassemia occurs when a gene or genes related to the alpha globin protein are missing or changed (mutated). Alpha thalassemias occur most commonly in persons from southeast Asia, the Middle East, China, and in those of African descent.
  • Beta thalassemia occurs when similar gene defects affect production of the beta globin protein. Beta thalassemias occur in persons of Mediterranean origin, and to a lesser extent, Chinese, other Asians, and African Americans.
  • There are many forms of thalassemia. Each type has many different subtypes. Both alpha and beta thalassemia include the following two forms:
  • Thalassemia major Beta thalassemia major is also called Cooley's anemia.
  • Thalassemia minor: You must inherit the defective gene from both parents to develop thalassemia major. Thalassemia minor occurs if you receive the defective gene from only one parent. Persons with this form of the disorder are carriers of the disease and usually do not have symptoms.

Who is at highest risk?

  • Asian,
  • Chinese,
  • Mediterranean, or
  • African American ethnicity
  • Family history of the disorder

When to seek urgent medical care?

Call for an appointment with your health care provider if:

  • You or your child has symptoms of thalassemia
  • You are being treated for the disorder and new symptoms develop


  • A physical exam may reveal a swollen (enlarged) spleen.
  • A blood sample will be taken and sent to a laboratory for examination.
  • Red blood cells will appear small and abnormally shaped when looked at under a microscope.
  • A complete blood count (CBC) reveals anemia.
  • A test called hemoglobin electrophoresis shows the presence of an abnormal form of hemoglobin.
  • A test called mutational analysis can help detect alpha thalassemia that cannot be seen with hemoglobin electrophoresis.

Treatment options

  • Treatment for thalassemia major often involves regular blood transfusions and folate supplements.
  • If you receive blood transfusions, you should not take iron supplements. Doing so can cause a high amount of iron to build up in the body, which can be harmful.
  • Persons who receive significant numbers of blood transfusions need a treatment called chelation therapy to remove excess iron from the body.
  • Bone marrow transplant may help treat the disease in some patients, especially children.

Medications to avoid

Patients diagnosed with thalassemia should avoid using the following medications:

  • Pegylated interferon alfa-2b
    If you have been diagnosed with thalassemia, consult your physician before starting or stopping any of these medications.

Where to find medical care for Thalassemia?

Directions to Hospitals Treating Thalassemia


Genetic counseling and prenatal screening may be available to those with a family history of this condition who are planning to have children.

What to expect (Outlook/Prognosis)?

  • Severe thalassemia can cause early death due to heart failure, usually between ages 20 and 30. Frequent blood transfusions with therapy to remove iron from the body helps improve the outcome.
  • Less severe forms of thalassemia usually do not result in a shorter life span.

Possible complications

  • Untreated, thalassemia major leads to heart failure and liver problems, and makes a person more likely to develop infections.
  • Blood transfusions can help control some symptoms, but may result in too much iron which can damage the heart, liver, and endocrine system.